| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.06 |